Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heat shock transcription factor family, X-linked member 4 (HSFX4) is a protein-coding gene in humans predicted to function as a DNA-binding transcription factor involved in regulating gene expression via RNA polymerase II[1][10][14][16]. HSFX4 possesses sequence-specific DNA-binding activity and is active in the cell nucleus[10][16][17]. The gene is paralogous to other heat shock factor family members and is associated in some studies with corneal dystrophy and Bardet-Biedl syndrome, but its precise physiological and pathological roles remain incompletely characterized in humans[10][12][14][17]. There are no well-documented small molecule or biologic drugs directly targeting HSFX4, nor established biomarker or safety concern data specific to this factor at the current time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock transcription factor family, X-linked member 4 (HSFX4).